Durect Corp (DC8A.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 09:59PM CEST
| Previous close | 0.8200 |
| Open | 0.8500 |
| Bid | 0.8250 x N/A |
| Ask | 0.8500 x N/A |
| Day's range | 0.8100 - 0.8500 |
| 52-week range | 0.4520 - 6.4000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...
Amidst revenue decline and significant cash burn, Durect Corp reports promising clinical trial results and strategic FDA interactions.
ZacksDurect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
Durect (DRRX) delivered earnings and revenue surprises of -19.05% and 33.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.